Key result
Post-CAS ischemic lesions on DWI are linked to a ~185% higher risk of recurrent stroke/TIA.
Why the study?
Does the presence of periprocedural ischemic DWI lesions after carotid artery stenting or endarterectomy increase the risk of recurrent cerebrovascular events in patients with symptomatic carotid stenosis?
RCT (n=231)
randomized
Yes
Does the presence of periprocedural ischemic DWI lesions after carotid artery stenting or endarterectomy increase the risk of recurrent cerebrovascular events in patients with symptomatic carotid stenosis?
Hazard Ratio: 2.85 (95% CI 1.05–7.72)
Absolute Event Rate: 22.8% vs 8.8%
p-value: p=0.04
Ischemic brain lesions detected on DWI after carotid artery stenting are associated with an increased risk of recurrent cerebrovascular events, suggesting these patients may benefit from more aggressive antiplatelet therapy.
BACKGROUND: Brain lesions on diffusion-weighted imaging (DWI) are frequently found after carotid artery stenting (CAS), but their clinical relevance remains unclear. OBJECTIVES: This study sought to investigate whether periprocedural ischemic DWI lesions after CAS or carotid endarterectomy (CEA) are associated with an increased risk of recurrent cerebrovascular events. METHODS: In the magnetic resonance imaging (MRI) substudy of ICSS (International Carotid Stenting Study), 231 patients with symptomatic carotid stenosis were randomized to undergo CAS (n=124) or CEA (n=107). MRIs were performed 1 to 7 days before and 1 to 3 days after treatment. The primary outcome event was stroke or transient ischemic attack in any territory occurring between the post-treatment MRI and the end of follow-up. Time to occurrence of the primary outcome event was compared between patients with (DWI+) and without (DWI-) new DWI lesions on the post-treatment scan in the CAS and CEA groups separately. RESULTS: Median time of follow-up was 4.1 years (interquartile range: 3.0 to 5.2). In the CAS group, recurrent stroke or transient ischemic attack occurred more often among DWI+ patients (12 of 62) than among DWI- patients (6 of 62), with a cumulative 5-year incidence of 22.8% (standard error [SE]: 7.1%) and 8.8% (SE: 3.8%), respectively (unadjusted hazard ratio: 2.85; 95% confidence interval: 1.05 to 7.72; p=0.04). In DWI+ and DWI- patients, 8 and 2 events, respectively, occurred within 6 months after treatment. In the CEA group, there was no difference in recurrent cerebrovascular events between DWI+ and DWI- patients. CONCLUSIONS: Ischemic brain lesions discovered on DWI after CAS seem to be a marker of increased risk for recurrent cerebrovascular events. Patients with periprocedural DWI lesions might benefit from more aggressive and prolonged antiplatelet therapy after CAS. (A Randomised Comparison of the Risks, Benefits and Cost Effectiveness of Primary Carotid Stenting With Carotid Endarterectomy: International Carotid Stenting Study; ISRCTN25337470).
No takes yet. Share an insight, caveat, or question.
Gensicke et al. (2015) conducted an RCT in symptomatic carotid stenosis (n=231). New ischemic brain lesions on DWI (DWI+) vs. No new ischemic brain lesions on DWI (DWI-) was evaluated on Stroke or transient ischemic attack in any territory occurring between the post-treatment MRI and the end of follow-up (HR 2.85, 95% CI 1.05-7.72, p=0.04). New ischemic brain lesions on DWI after carotid artery stenting increased the risk of recurrent stroke or TIA compared to patients without new lesions (HR 2.85; 95% CI 1.05-7.72; p=0.04).
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: